Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Joel Rosenblatt, PhD

Laboratory Manager
MD Anderson UT

Disclosure(s): No financial relationships to disclose

Poster(s):

1714 - In Vitro Activity of Tebipenem Against Clinically Significant Gram-Positive Bacteria Isolated from Patients with Cancer
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET